drugset / Trial / NCT03714438

Effect of Medicago Sativa on Oral Glucose Tolerance in Healthy Adults

NCT03714438

Phase 2 Completed 15 enrolled University of Guadalajara
RandomizedCrossoverTriple-blindTreatment

Summary

Previous preclinical investigations have found that Medicago sativa promotes the decrease of glucose concentrations. To evaluate the acute effect of Medicago sativa administration on glucose tolerance, insulin secretion, and insulin sensitivity in healthy individuals.

Timeline

Start
2017-02-07
Primary completion
2018-01-11
Completion
2018-01-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Medicago Sativa Unknown 1500 mg Oral

Indications